chrisvoncsefalvay/vaers-outcomes huggingface dataset:
severe diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (severe diarrhea) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (severe diarrhea). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM AD) for Diarrhea, at an unspecified dose and frequency; BISMUTH SUBSALICYLATE (PEPTO-BISMOL) for Diarrhea, at an unspecified dose and frequency; DEXTRIN (BENEFIBER [DEXTRIN]) for Diarrhea, at an unspecified dose and frequency and LOPERAMIDE HYDROCHLORIDE (LOMOTIL [LOPERAMIDE HYDROCHLORIDE]) for Diarrhea, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (severe diarrhea) had not resolved.            Concomitant product use was not provided.
5 days following receipt of the COVID Moderna vaccine, patient showed signs of a rash on the upper right part of his back, his chest, and upper right arm and underarm.  Day 5 following vaccination it got worse, the red area spreading and developing blisters.  1 week following vaccination, visited urgent care and was diagnosed with Shingles. (Zoster witout complications) and given prescription for valacycolvir 1g tablet by mouth 3x a day for 7 days
Significant erythema, mild streaking. Diagnosis: cellulitis, abscess, lymphangitis.
COVID incident after being fully vaccinated; COVID incident after being fully vaccinated; This is a spontaneous report from a contactable physician. A 47-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EW0151), dose 1 via an unspecified route of administration on 14Apr2021 as DOSE 1, SINGLE, dose 2 via an unspecified route of administration and on 05May2021 (Batch/Lot Number: ER8735) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient experienced a breakthrough COVID incident after being fully vaccinated. Symptoms were mild included runny nose, congestion, loss of taste and smell and a positive COVID test received on 25Aug2021. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 25Aug2021. The outcome of events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2 to the vaccination failure (LOE)  cannot be ruled out.The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
patient felt lightheaded and nauseous suddenly on the morning after the 2nd covid vaccine.  she tried to lower herself to the floor, but blacked out and hit her head, requiring staples.  she is still experiencing extreme fatigue, which is unusual for her.  she is highly functional at baseline.
Initial report received from a health care professional on Jul 01 2005. A 12 year old female patient received an injection of Menactra, lot number U1640AA, in the left deltoid and an injection of Decavac, lot number U1563DA, in the right deltoid on June 19 2005. One day later, she developed tenderness and warmth measuring 1 1/2 in x 1 1/3 in. at the site of the Menactra vaccination. She was examined by a physician and diagnosed with possible cellulitis. The patient received corrective treatment with Keflex and Bactrim. At the time of this report, the patient had not recovered from these events.
Jerky movements-seizure like for about 30 seconds to a minute IMMEDIATELY with the administration of the HPV vaccine (pt already had gotten the Meningitis B vaccine about 5 minutes prior (this was pt's 2nd Meningitis B vaccine dose and he had NO problem with the first dose of it six months prior vasovagal reaction (pale, low blood pressure)--recovered with monitoring rest and oral fluids within one hour.
Patient presented to the ED and was subsequently hospitalized for STEMI, spontaneous dissection of coronary artery within 6 weeks of receiving covid vaccination.
APHASIA THAT LASTED ABOUT AN HOUR. COULD NOT FORM WORDS. ADMITTED TO HOSPITAL FOR OVER NIGHT OBSERVATION AND TESTS. VALSARTAN DOSE INCREASED FROM 40 TO 80 MG  1/DAY.   CORRECTED DEHYDRATION CONDITION.
Heart rate felt like it was up right before bed, woke @ 1:30 with a headache went to use the bathroom and take Ibuprofen and passed out before I could take it. really thirsty during the rest of the night, woke up @ 5:30am to go to work but felt really lightheaded and still really dizzy, this continued throughout the day, still feel a bit wobbly today but not as bad. Also have had cold chills with hot flashes through the whole time.I was able to email my Dr today about my symptoms. *I did have the shot at the Emergency Room due to Allergy to Hep B shot in the past.*
After vaccine 3 days of chills, redness and heat. 8/22/17 seen in UC throbbing pain full extension of arm limited due to pain, no redness or swelling. Pt. sent to Hospital ER for further evaluation.
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in an unspecified number of adult patients who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: This case was reported for the patients who had warned the reporter regarding the vaccine. The age at vaccination was not reported. After receiving vaccine, the patients experienced flu like symptoms. This is 1 of 2 cases, reported by the same reporter.
small swollen lymph node under her chin; This is a spontaneous report from a contactable consumer (patient). A 35-year-old female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EJ1685), via an unspecified route of administration in upper right arm on 17Dec2020 15:00 at single dose for vaccination. Medical history and concomitant medications were none. The patient who was administered the first dose of Pfizer COVID-19 Vaccine on 17Dec2020. She developed a small swollen lymph node under her chin on 19Dec2020 which was ongoing. She called to ask if the small swollen lymph node would be considered a serious adverse event; and if she should or should not still receive the second dose of Pfizer COVID-19 Vaccine as scheduled for today. The outcome of event was not recovered.
Approximately 8 min after receiving vaccine patient reports Tightness in chest and limbs, light headed, anxious
Case previously recorded as MA2009-3505. Initial case report received from a nurse via MedCom on 29 Oct 2009. An 8-month-old male patient was vaccinated with 0.5 ml S-OIV FLUVIRIN (batch no. unknown) i.m. into the right deltoid on 29 OCT 2009. No adverse event was reported. MedCom reference no.: NA09-007260.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 66-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Oct2022 as dose 5 (booster), single (Lot number: GH9697) at the age of 65 years, in right arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 04Mar2021 as dose 1, single (Lot number: EN6199), in right arm, on 26Mar2021 as dose 2, single (Lot number: EP6955), in right arm, on 04Sep2021 as dose 3 (booster), single (Lot number: FC3183), in right arm and on 15Jun2022 as dose 4 (booster), single (Lot number: FM7553), in right arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Penicillin" (unspecified if ongoing); "Cancer", start date: 2017 (unspecified if ongoing); "sensory hearing loss" (unspecified if ongoing); "vertigo" (unspecified if ongoing); "tinnitus" (unspecified if ongoing), notes: 20000. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 23Sep2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 (Paxlovid).
This spontaneous report as received from a pharmacist via company representative refers to 2 female patients of unknown ages. On unknown dates the patients were vaccinated with PNEUMOVAX23 (lot # not reported) (total daily dose not reported). It was reported that the 2 patients came back to the pharmacy on separate days with red throbbing reactions at their PNEUNOVAX23 injection sites. Both patients were vaccinated from the same lot # and expiration date. The outcome was unknown. It was also reported that the administering pharmacist contacted the other 7 patients who had also been vaccinated from this lot # and expiration date and no other reactions were reported. Additional information has been requested.
About 3 or 4 hours after the injection I began to experience extreme dizziness making it difficult to walk. After about 12 hours flu like symptoms, sweating and burning set in. Three days let heavy chest pains began. The flu like symptoms went away after a couple days but a 'brain fog' lasted for two weeks. Six weeks later I continue to experience dizziness although it is lessened over time and chest pains also continue. I made an appointment with my doctor after 4 weeks of continuing side effects to get an evaluation.  My chest was examined and  blood was drawn for a test and I was advised to fill out a VAERS report.
Woke up Sunday morning with bloody nose...bruises all over my body...had a million red dots  all over my body....capillaries were bleeding under skin ...this is called....Petechiae Went to doctor Monday ....platelet count was negative two...was rushed to hospital...a week in hospital...still getting infusions weekly due to adverse vaccine reaction...research showed I was number 37 who had this reaction and one person had died due to this...my doctor is now treating three additional patients with this....SOMETHING MUST BE DONE....I feel compensation for my pain and suffering and way of life has changed....had to have a port placed to have infusions...I am tired all the time because platelets are so low...limited activity due to necessary infusions weekly...frequent headaches...stressed...depressed...bruise easily.....fear of contacting COVID because I can?t get second vaccine...
Pneumovax administered 4/21/03. Severe pain at site within 2-3 hours. Progressed to extreme nausea, headache, fatigue, and local rx approximately 4 inches in length. Erythematous, slightly red, hot to touch, weakness in limb.
At around 6pm, 4 hours after receiving the vaccines, I experienced about 30 minutes of significantly increased energy.  At around 6:30pm, extreme fatigue set in that has continued through today, Monday, October 2.  On Friday, September 29, the fatigue increased substantially and I had trouble staying awake.  I began to lose my voice, and experienced pericoronitis, or swelling or the tissue around my right molars.  Throughout this entire time, I have had significant brain fog and an inability to think clearly.  These symptoms are beginning to resolve after several days of rest.
Pt recvd vax & still did not respond; 30AUG92 devel fatigue, diarrhea, joints hurt & could not bend wrists; seen in ER;
Patient wanted both immunizations in the same arm. Utilized the upper deltoid for the FLUCLVAX and lower portion of the deltoid for the PNEUMOVAX.  Patient did not report any symptoms until 9/28/17.  Patient reported symptoms started the day after the immunizations with her arm swelling up "like a balloon" and she experienced chills and feeling of generalized weakness for the next few days.  Five days later when she reported to the pharmacy her arm was still a little red but not swollen. The central part of the redness looked like the reaction would have come from the pneumovax which was the lower portion of the deltoid.
Mild redness/tenderness at injection site, persistent over course of several days. Patient notified clinic of redness, was advised to apply cool compresses, dose ibuprofen/acetaminophen as needed for pain, and to try diphenhydramine 25-50mg dosing to help reduce local reaction.  Patient advised to seek further medical attention if worsening redness/pain.
Patient was 16 at time of vaccination. Moderna is only approved for those 18 years and older
within 24 hours of vaccination: swelling and itching of eyes, swelling of hand/feet. Patient had some relief with Benedryl previous to ER visit. Patient given Atarax and Zantac in ER.  Probable reaction to vaccine component.  Follow up information received on 04/16/2003 states:   3/23/03 - headache 3/24/03 - Disorientation, hospitalization, admission Dx encephalitis 3/27/03 - Discharge from hospital, final Dx encephalitis or bacterial meningitis.
A nurse reported that a male received an injection of Flu Shield (2001-2002 Formula) on 30 NOV 2001. That day, he developed pain at the injection site which was still present after two weeks. No further information was available at the date of this report.
Headache  Nausea  Joint pain Fatigue  Tiredness  Hives/rash
3 in by 7in rash on (L) arm. Warm, raised & red. Not itchy.
Heavy and irregular menstrual cycle. Went from very light and every 3 months to heavy and much more frequent, with spotting and cramps on between.
Patient started feeling dizzy, and had blurry vision right after covid 19 updated booster bivalent, and had a minute of black out then came back to herself afterwards even though she looked pale
pt recvd vax; pt exp nausea & devel vomiting & bronchospasms; tx w/ epinephrine;
After administration of Hep B 3 + DTaP. Her body temperature remained excessively hot for several years. 2007 she developed a viral and could not break fever for 3 1/2 weeks. When she finally, recovered she developed large white spots on face and body. She was diagnosed with Vitiligo and auto immune disorder.  4/11/08-records received for office visits-10/7/00-C/O crying, TM erythematous, dull. Left OM. Poor appetite. 10/23/00-nasal congestion, TMs right injected. 12/4/00-Fever, runny nose. 12/7/00-diaper rash.12/9/00-Fever times 2 days. TM with fluid bilateral. . 1/15/01-congested times 5-6 days. 4/1/01-L TM erythematous, dull with pus.6/5/01-C/O rash on arms and stomach, fever times 4 days. 9/1/01-C/O abnormal gait, falling a lot while walking. Referred to neurologist, patient has not returned to PCP since referral.  5/22/08-records received for office visit 11/14/07-for evaluation and treatment of vitiligo which was diagnosed a few months ago. White spots began around 8 months ago. DX: Vitiligo with depigmented macules limited to right periorbital area, right abdomen and right upper extremity.
Patient C/O red rash noted for 3-4 days following vaccination. Fine red rash that was warm to touch noted upon assessment. No S/S of infection noted upon assessment.
I experienced a fever, cough, shortness of breathe, body aches, chills, arm swollen, general flu like symptoms that began the night of injection and lasted for 48 hours.
I developed a very servere case of hives and I had a terrible case of acid reflux which kept me up ALL NIGHT LONG prompted me to go to the emergency care unit and get a ekg, back in Jauary 2021.
Dizziness developed 10 minutes post vaccine.  Lasted 30 minutes.  EMS called with no transport.
Expired dose; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Oct-2021 at 11:01 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose). On 18-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment  medications were reported.   19 doses of Moderna was administered to 19 patients. The Moderna vial (10 dose, 0.5ml) was removed from the freezer to the refrigerator on 11 Oct 2021 without any temperature variations in the transfer from the freezer.The solution was off white in color.  No variation in color from all the other previously used vials.16 patients received 0.25 ml booster dose and 3 patients received 0.5 ml full dose. All patients tolerated vaccine administration well, without any complications in the office after observed for 15 minutes per protocol. As of 18 Oct 2021, no adverse reactions have been reported to our office staff or medical staff. No concomitants were reported. No treatment was reported.
On march 21,  patient noticed wekness and pain with left eye. difficulty eating with left side of face. has let facial droop, left eyebrow weakness, dimished gag reflex, taste left handed, acute onset, age-sent to higher level of care to ruse out acute CVA
Information has been received from a registered nurse concerning a woman who was vaccinated with a dose of MMR II as a child. Subsequently, the pt developed a "physical disability as a result of the vaccine." Follow up information received from a health professional indicated that the woman was not the patient. The woman had reported to the nurse that a child in her neighborhood had an adverse event after bein vaccinated with MMR (second geneation). The woman had also seen a television show on vaccines and had searthed the internet. As a result, the woman refused to have her own son vaccinated with a booster dose of MMR (second generation). The woman's son had received the first dose with no adverse events. Upon internal review, "physical disability" was determined to be an other important medical event. Additional info has been requested.
Blister type places on foot first.  then legs, turns red then hard, not itchy.  red discoloration on bottoms of feet, have red discoloration still it is itchy.  arms have red spots itchy back is starting to itch i dont know if has spots
Child admitted in care on 8/6/2022. Seen for his health assessment with PCP on 8/8/2022. Child received incorrect dose on 8/16/2022 based on historical data. System updated with historical information by medical coordinator on 8/16. Assigned transfer of file. NP made aware of the scenario and stated no recommendations at this time due to more than 24 hours of incident. No reports of adverse reaction.
Both hands developed pain and the white color pattern of Reynaud's phenomenon that evening when I was out in the cold  briefly.  The symptoms  resolved after a couple hours.  I had no recurrence of this after the second vaccine dose, or when out in severely cold weather in January 2021.  I've never had these symptoms before.  My father had Reynaud's disease that began when he was in his fifties.
Immediately experienced chills;  elevated pulse/heart rate and low oxygen; elevated fever; pulse/heart rate went to 120; fever went to 102.5; and oxygen at 94.   After 4 hours, metrics returned to within normal range.   Weak and tired the rest of evening and into the next day.
Vaccination given to female age 17 years, 9 months old.   Parental consent on file.
Ringing in left and right ear. Ringing has been constant for 10 days.
Soreness at site of injection began at approximately 7 pm on 10/29/2011. Nausea and stomach ache noticeable after midnight. Fainted 2 times on the way to bathroom. Experienced diarrhea. Fainted once more on the way back to bedroom. Symptons disappeared after a night's sleep.
A report was received from a health care professional on 10/25/02, concerning a vaccinee of unknown demography who experienced short term memory loss, two hours after receiving Fluvirin IM in 10/02. It was reported initially on 10/25/02 that in October,2002, the vaccinee experienced memory loss for approximately 24 hours after receiving 0.5ml Fluvirin IM in October, 2002. The symptom was reported to be "self-limiting'. It was reported that the vaccinee did not receive medical intervention and recovered without sequelae. follow-up information received on 11/06/02;an addendum was received which reported that the vaccinee was a 76 year old female who was vaccinated on 10/19/02 with Fluvirin (batch # E34692HA) and experienced short term memory lose for two days and injection site local reaction of pain, redness and swelling and had resolved within 2 days of onset. All symptoms were self-limiting. On an unknown date, the vaccinee was admitted to hospital due to memory loss and underwent a MRI examination, the results of which were found to be normal. The reporter did not have information on the past medical and drug history of the patient. There was insufficient information to determine the reporter's causality assessment.  Follow up on 12/23/2002: "Follow up information received on 12/11/2002: a follow-up was received which reported that the vaccinee experienced stinging when she received the vaccine followed later by pain in the right arm.  The redness was the size of a jar lid/large lump.  It was also reported that the redness and swelling lasted for 7 days and the vaccinee was hospitalized for 3 days.  It was reported that no other medical diagnosis was made and the vaccinee has had no symptoms since.  The outcome was reported as resolved.  The batch number has been confirmed as E3469244A and not E24692MA as previously reported which is not identified as a batch number.  It was reported that the vaccinee had a previous incident of memory loss following pneumovax administration.  The reporter did not have information on drug history of the patient.  There was insufficient information to determine the reporter's causality assessment."